Jeffrey H Knapp - Net Worth and Insider Trading

Jeffrey H Knapp Net Worth

The estimated net worth of Jeffrey H Knapp is at least $18 dollars as of 2024-04-27. Jeffrey H Knapp is the Chief Commercial Officer of Affymax Inc and owns about 25,169 shares of Affymax Inc (AFFY) stock worth over $18. Details can be seen in Jeffrey H Knapp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey H Knapp has not made any transactions after 2012-03-27 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey H Knapp

To

Jeffrey H Knapp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey H Knapp owns 3 companies in total, including Aimmune Therapeutics Inc (AIMT) , Adamas Pharmaceuticals Inc (ADMS) , and Affymax Inc (AFFY) .

Click here to see the complete history of Jeffrey H Knapp’s form 4 insider trades.

Insider Ownership Summary of Jeffrey H Knapp

Ticker Comapny Transaction Date Type of Owner
AIMT Aimmune Therapeutics Inc 2018-03-04 Chief Operating Officer
ADMS Adamas Pharmaceuticals Inc 2015-02-25 Chief Operating Officer
AFFY Affymax Inc 2013-02-15 Chief Commercial Officer

Jeffrey H Knapp Latest Holdings Summary

Jeffrey H Knapp currently owns a total of 1 stock. Jeffrey H Knapp owns 25,169 shares of Affymax Inc (AFFY) as of March 27, 2012, with a value of $18.

Latest Holdings of Jeffrey H Knapp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AFFY Affymax Inc 2012-03-27 25,169 0.00 18

Holding Weightings of Jeffrey H Knapp


Jeffrey H Knapp Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey H Knapp has made a total of 0 transactions in Affymax Inc (AFFY) over the past 5 years. The most-recent trade in Affymax Inc is the sale of 0 shares on March 27, 2012, which brought Jeffrey H Knapp around $0.

Insider Trading History of Jeffrey H Knapp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey H Knapp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey H Knapp Ownership Network

Ownership Network List of Jeffrey H Knapp

No Data

Ownership Network Relation of Jeffrey H Knapp


Jeffrey H Knapp Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Jeffrey H Knapp is the Chief Operating Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aimmune Therapeutics Inc Insider Transactions

No Available Data

Jeffrey H Knapp Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey H Knapp. You might contact Jeffrey H Knapp via mailing address: 4001 Miranda Ave. Palo Alto Ca 94304.

Discussions on Jeffrey H Knapp

No discussions yet.